Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of Moderate Buy by Brokerages

Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has earned an average rating of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among […]

Related Keywords

Alger ,Algeria ,Canada ,United States ,Piper Sandler ,Stifel Nicolaus ,News Ratings For Health Catalyst Daily ,Vanguard Group Inc ,Institutional Trading Of Health Catalyst ,Daventry Group ,Health Catalyst ,Health Catalyst Inc ,Clearbridge Investments ,Royal Bank ,Cantor Fitzgerald ,Nasdaq ,Health Catalyst Trading ,Health Catalyst Company Profile ,First Light Asset Management ,Analyst Recommendations For Health Catalyst ,Get Free Report ,Light Asset Management ,Get Free ,Health Catalyst Daily ,Nasdaq Hcat ,Thcat ,Medical ,Ratings ,Consensus ,